Diagnostics

  • Phoenix Hospital Group launches new Prostate MRI Cancer Screening Service

    Phoenix Hospital Group has announced the launch of its new Prostate MRI Cancer Screening Service, now available at its Harley Street Health District hospital in central London and at Phoenix Chelmsford Hospital in Essex. The service has been introduced to encourage men to take a proactive approach to their wellbeing.  The Group also offers prostate [...]

  • Blood test detects brain tumours with 90% accuracy

    Scientists have made a significant step towards a blood test that detects brain tumours and monitors them in real time. The new test is 90 per cent accurate and could be used by GPs to pick up glioblastomas. It is also being expanded to include other types of brain tumour. The study, led by scientists [...]

  • Women’s health screening in 2026: Why combining GP assessment, ultrasound and genetics delivers better outcomes

    Article produced in association with Spital Clinic and Jeen Health The Women's Health Strategy for England, published in 2022, identified significant gaps in how women's health needs are met across the life course. Among the issues highlighted were poor access to specialists, delays in diagnosis for conditions such as endometriosis and PCOS, and a healthcare [...]

  • Magentus launches UK advisory board to strengthen clinical diagnostics strategy

    Magentus, a leading name in clinical diagnostics, announces the formation of a UK Advisory Board to guide the next phase of its strategy and reaffirm its long-term commitment to the UK health system. The announcement marks a significant milestone in Magentus’ renewed leadership in the UK market. It reinforces the company’s focus on earlier diagnosis, [...]

  • Earlier liver disease detection means better outcomes – and you can make the difference

    By Dr Tim Jobson, medical director, Predictive Health Intelligence “Intervention timing is everything. Case-finding enables this”  Chronic liver disease is often diagnosed only after emergency presentation, when treatment options are limited and damage is irreversible. Because the disease is silent and carries stigma, patients are less likely to seek medical advice. At the same time, [...]

  • Guardant Health acquires MetaSight in US$150m deal

    Guardant Health has acquired Israeli diagnostics startup MetaSight in a deal valued at up to US$150m, highlighting growing international investment in Israel’s health technology sector. The agreement includes US$60m in upfront cash, before standard deductions, along with up to US$90m in contingent payments tied to future performance milestones. The acquisition is expected to accelerate the [...]

  • Simed Global forms rapid diagnostics partnership with India’s HiMedia Laboratories

    Simed Global has partnered with HiMedia Laboratories to develop rapid diagnostic technologies. The Birkenhead-based health technologies firm said the collaboration aims to accelerate the development, validation and worldwide adoption of rapid diagnostics. Simed Global said its instant diagnostic platform will be supported by Maharashtra-based HiMedia Laboratories, which specialises in life science and microbiology [...]

  • SGS partners with theblood to develop women’s health diagnostics

    SGS has partnered with Berlin-based health tech startup theblood to develop menstrual diagnostics for women’s health using menstrual blood. The tie-up aims to build the scientific and regulatory case for using menstrual fluid as a non-invasive source of health data. Menstrual blood contains biomarkers, biological indicators that can signal disease, and could help detect conditions [...]

  • New finger-prick blood test could aid Alzheimer’s diagnosis

    A finger-prick test is being trialled in the UK, US and Canada to see if it can help diagnose Alzheimer’s disease in people aged over 60. The study involves 1,000 volunteers and will look for biomarkers linked to Alzheimer’s by analysing blood from a simple finger-prick. Biomarkers are measurable signs in the body, and researchers [...]

  • Women’s health ‘proves itself’ with exits surpassing US$100bn

    Women’s health exits topped US$100bn in acquisitions and IPOs from 2000 to 2025, according to new research. Released at the JPMorgan Healthcare Conference in San Francisco, the research logs 276 exits and 27 billion-dollar deals, including US$27bn in transactions in 2025 alone, the biggest year on record for the category. The report, Follow the Exits: [...]

Promotional banner for Health Tech World Live: The future of healthcare AI event at Queen Elizabeth Olympic Park, London, Friday 21 August, 12–4pm. Book now button visible, bright teal accents.